Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.
Alliance Pharma Dividend Announcement
• Alliance Pharma announced a quarterly dividend of £1.18 per ordinary share which will be made payable on 2023-07-18. Ex dividend date: 2023-06-22
• Alliance Pharma annual dividend for 2023 was £1.18
• Alliance Pharma's trailing twelve-month (TTM) dividend yield is -%
• Alliance Pharma's payout ratio for the trailing twelve months (TTM) is -19.04%
• Alliance Pharma's dividend growth over the last five years (2018-2023) was -2.95% year
• Alliance Pharma's dividend growth over the last ten years (2013-2023) was 3.33% year
Alliance Pharma Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2023-06-22 | £1.18 | quarterly | 2023-07-18 |
2022-12-22 | £0.59 | quarterly | 2023-01-19 |
2022-06-09 | £1.13 | quarterly | 2022-07-07 |
2021-12-23 | £0.56 | quarterly | 2022-01-07 |
2021-12-16 | £0.56 | quarterly | 2022-01-07 |
2021-06-10 | £1.07 | quarterly | 2021-07-08 |
2020-12-17 | £0.54 | quarterly | 2021-01-07 |
2019-12-19 | £0.54 | quarterly | 2020-01-10 |
2019-06-13 | £0.98 | quarterly | 2019-07-11 |
2018-12-20 | £0.49 | quarterly | 2019-01-10 |
2018-06-14 | £0.89 | quarterly | 2018-07-11 |
2017-12-21 | £0.44 | quarterly | 2018-01-11 |
2017-06-15 | £0.81 | quarterly | 2017-07-12 |
2016-12-22 | £0.40 | quarterly | 2017-01-12 |
2016-06-16 | £0.73 | quarterly | 2016-07-13 |
2015-12-24 | £0.37 | quarterly | 2016-01-14 |
2015-06-18 | £0.67 | quarterly | 2015-07-15 |
2014-12-04 | £0.33 | quarterly | 2015-01-15 |
2014-06-11 | £0.60 | quarterly | 2014-07-10 |
2013-12-04 | £0.30 | quarterly | 2014-01-15 |
2013-06-12 | £0.55 | quarterly | 2013-07-11 |
2012-12-05 | £0.28 | quarterly | 2013-01-15 |
2012-06-13 | £0.50 | quarterly | 2012-07-12 |
Alliance Pharma Dividend per year
Alliance Pharma Dividend growth
Alliance Pharma Dividend Yield
Alliance Pharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Alliance Pharma stock? Use our calculator to estimate your expected dividend yield:
Alliance Pharma Financial Ratios
Alliance Pharma Dividend FAQ
Other factors to consider when evaluating Alliance Pharma as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Alliance Pharma stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Alliance Pharma's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Alliance Pharma publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Alliance Pharma distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Alliance Pharma are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Alliance Pharma sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Alliance Pharma distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Alliance Pharma declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Alliance Pharma's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Alliance Pharma's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.